Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
MedAlign: A Synergistic Framework of Multimodal Preference Optimization and Federated Meta-Cognitive Reasoning
arXiv:2510.21093v1 Announce Type: new Abstract: Recently, large models have shown significant potential for smart healthcare. However, the deployment of Large Vision-Language Models (LVLMs) for clinical services is currently hindered by three critical challenges: a tendency to hallucinate answers not grounded in visual evidence, the inefficiency of fixed-depth reasoning, and the difficulty of multi-institutional collaboration. To address these challenges, in this paper, we develop MedAlign, a n
-
Omics In Lung
-
Integrated multi-omics analysis and experimental investigation of mitochondrial dynamics-related genes: molecular subtypes, immune landscape, and prognostic implications in lung adenocarcinoma
Front Immunol. 2025 May 29;16:1585505. doi: 10.3389/fimmu.2025.1585505. eCollection 2025.ABSTRACTBACKGROUND: Lung adenocarcinoma (LUAD) is a common and aggressive subtype of lung cancer associated with poor clinical outcomes. The role of mitochondrial dynamics (MD)-related genes in tumor progression and immune regulation remains poorly understood.METHODS: Data from public databases were integrated, and subtypes were classified based on 23 MD-related genes. A five-gene prognostic model was constr
Integrated multi-omics analysis and experimental investigation of mitochondrial dynamics-related genes: molecular subtypes, immune landscape, and prognostic implications in lung adenocarcinoma
Front Immunol. 2025 May 29;16:1585505. doi: 10.3389/fimmu.2025.1585505. eCollection 2025.
ABSTRACT
BACKGROUND: Lung adenocarcinoma (LUAD) is a common and aggressive subtype of lung cancer associated with poor clinical outcomes. The role of mitochondrial dynamics (MD)-related genes in tumor progression and immune regulation remains poorly understood.
METHODS: Data from public databases were integrated, and subtypes were classified based on 23 MD-related genes. A five-gene prognostic model was constructed. Associations between the model and immune infiltration, tumor mutational burden (TMB), tumor stemness, and drug sensitivity were analyzed. The function of the key gene MTCH2 was validated through in vitro experiments.
RESULTS: Two distinct MD molecular subtypes were identified, exhibiting significant differences in prognosis and immune characteristics. A corresponding risk score model was established. Patients in the low-risk group showed better prognosis and enhanced immune activity, whereas the high-risk group displayed higher TMB and stemness scores. Drug sensitivity analysis revealed distinct responses to chemotherapeutic agents such as cisplatin and docetaxel between risk groups. Functional assays demonstrated that MTCH2 knockout significantly inhibited LUAD cell proliferation, migration, and invasion, and induced G0/G1 phase arrest, suggesting that MTCH2 may act as a potential adverse prognostic marker.
CONCLUSION: MD-related genes exhibit strong prognostic and immune subtyping value. The proposed risk model holds clinical potential, and MTCH2 may serve as a promising target for precision therapy in LUAD.
PMID:40510359 | PMC:PMC12159055 | DOI:10.3389/fimmu.2025.1585505
-
Nature - Issue - nature.com science feeds
-
A fully open AI foundation model applied to chest radiography
Nature, Published online: 11 June 2025; doi:10.1038/s41586-025-09079-8Ark+, a fully open artificial intelligence foundation model, demonstrates exceptional capabilities in diagnosing common, rare and novel thoracic diseases.
A fully open AI foundation model applied to chest radiography
Nature, Published online: 11 June 2025; doi:10.1038/s41586-025-09079-8
Ark+, a fully open artificial intelligence foundation model, demonstrates exceptional capabilities in diagnosing common, rare and novel thoracic diseases.-
Nature - Issue - nature.com science feeds
-
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature, Published online: 08 February 2024; doi:10.1038/s41586-024-07051-6Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature, Published online: 08 February 2024; doi:10.1038/s41586-024-07051-6
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City-
Nature Biotechnology - Issue - nature.com science feeds
-
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation
Nature Biotechnology, Published online: 18 October 2023; doi:10.1038/s41587-023-02025-xAuthor Correction: Enhancing untargeted metabolomics using metadata-based source annotation
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation
Nature Biotechnology, Published online: 18 October 2023; doi:10.1038/s41587-023-02025-x
Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation-
Nature - Issue - nature.com science feeds
-
Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature, Published online: 11 October 2023; doi:10.1038/s41586-023-06595-3Genotype and exome sequencing of 150,000 participants and whole-genome sequencing of 9,950 selected individuals recruited into the Mexico City Prospective Study constitute a valuable, publicly available resource of non-European sequencing data.
Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature, Published online: 11 October 2023; doi:10.1038/s41586-023-06595-3
Genotype and exome sequencing of 150,000 participants and whole-genome sequencing of 9,950 selected individuals recruited into the Mexico City Prospective Study constitute a valuable, publicly available resource of non-European sequencing data.